Cardiac Biomarkers Market to Grow at 14.2% CAGR Through 2032 Amid Rising Demand for Early Detection and Point-of-Care Testing

Industry Experts, Inc. has released a comprehensive new market research report titled " Global Cardiac Biomarkers Market - Types, Applications and Testing Locations." According to the report, the global market for cardiac biomarkers is projected to rise from US$22.7 billion in 2025 to US$57.5 billion by 2032, expanding at a CAGR of 14.2% during the forecast period. The global burden of cardiovascular disease continues to rise, driving strong demand for early, non-invasive diagnostics. Biomarkers such as troponins, BNP/NT-proBNP, and hs-CRP are essential for rapid triage, risk assessment, and treatment guidance in both acute and chronic settings. The market is benefiting from increased adoption of point-of-care platforms, personalized medicine, and AI-enhanced testing. North America leads with a 41.8% share in 2025, supported by clinical innovation and FDA-backed adoption, while Asia Pacific is the fastest-growing region, projected to register over 16% CAGR t...